DNA Script
French tech company | Builders Republic
About
Maker of the SYNTAX® Platform, a benchtop enzymatic DNA synthesis instrument that lets biotech, pharma, and research labs produce custom single-stranded DNA oligonucleotides overnight in-house — eliminating reliance on external synthesis suppliers and accelerating design-build-test-learn cycles.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series C
- Founded
- 2014
- City
- LE KREMLIN-BICETRE
- Region
- IDF
- Legal name
- DNA SCRIPT
- SIREN
- 801172834
- Tracked rounds
- 2
- Amount raised
- 76 M€ raised since 2020
Funding rounds
- Series C — 2022
- Extension — 2020
Investors
- Agilent Technologies
- Bpifrance Large Venture
- Casdin Capital
- Catalio Capital Management
- Coatue Management
- Columbia Threadneedle Investments
- Danaher LifeSciences
- Eurazeo
- eureKARE
- Fidelity
- Healthcor Management
- Illumina Ventures
- Irving Investors
- Kurma Partners
- LSP
- Merck Ventures
- Sofinnova